Carmen Uhlmann1, Susanne Jaeger2, Tilman Steinert2, Petra Schmid2. 1. Versorgungsforschung Weissenau, ZfP Südwürttemberg, Klinik I für Psychiatrie und Psychotherapie, Universität Ulm, Weingartshofer Str. 2, 88214, Ravensburg-Weissenau, Deutschland. carmen.uhlmann@zfp-zentrum.de. 2. Versorgungsforschung Weissenau, ZfP Südwürttemberg, Klinik I für Psychiatrie und Psychotherapie, Universität Ulm, Weingartshofer Str. 2, 88214, Ravensburg-Weissenau, Deutschland.
Abstract
BACKGROUND: Inpatient care for patients with depressive and anxiety disorders (ICD-10 F3/F4 diagnoses) is provided in Germany in different settings of psychiatry and psychosomatic medicine. OBJECTIVE: Apart from the question of the effectiveness of treatment, it is of interest whether the course of the disease differs between four different settings up to a period of 1 year after discharge. MATERIAL AND METHODS: A total of 320 patients with main clinical diagnoses from the ICD-10 F3/F4 spectrum were recruited and interviewed consecutively in four treatment settings (psychiatric depression unit, psychiatric crisis intervention unit, psychiatric day hospital, psychosomatic acute hospital). The interviews were conducted after admission, before discharge and 6 and 12 months after discharge. RESULTS: Overall, treatment in all four settings was shown to be highly effective. The slight increase in symptoms in the postinpatient phase described in the literature was observed across all settings. In terms of treatment intensity, those treated in the crisis intervention unit received the most services after index treatment; however, this group was also the one with the most pronounced symptom burden at admission. Patients treated in the psychosomatic department had the lowest symptom burden at admission and overall received the least inpatient services over the observation period; however, outpatient follow-up treatment was apparently used most by those patients. CONCLUSION: The treatments proved to be effective in the long-term in both psychiatric and psychosomatic units. The different settings seem to be successful in adapting the treatments to the respective patient groups.
BACKGROUND: Inpatient care for patients with depressive and anxiety disorders (ICD-10 F3/F4 diagnoses) is provided in Germany in different settings of psychiatry and psychosomatic medicine. OBJECTIVE: Apart from the question of the effectiveness of treatment, it is of interest whether the course of the disease differs between four different settings up to a period of 1 year after discharge. MATERIAL AND METHODS: A total of 320 patients with main clinical diagnoses from the ICD-10 F3/F4 spectrum were recruited and interviewed consecutively in four treatment settings (psychiatric depression unit, psychiatric crisis intervention unit, psychiatric day hospital, psychosomatic acute hospital). The interviews were conducted after admission, before discharge and 6 and 12 months after discharge. RESULTS: Overall, treatment in all four settings was shown to be highly effective. The slight increase in symptoms in the postinpatient phase described in the literature was observed across all settings. In terms of treatment intensity, those treated in the crisis intervention unit received the most services after index treatment; however, this group was also the one with the most pronounced symptom burden at admission. Patients treated in the psychosomatic department had the lowest symptom burden at admission and overall received the least inpatient services over the observation period; however, outpatient follow-up treatment was apparently used most by those patients. CONCLUSION: The treatments proved to be effective in the long-term in both psychiatric and psychosomatic units. The different settings seem to be successful in adapting the treatments to the respective patient groups.
Authors: Thomas Probst; Friedrich von Heymann; Michael Zaudig; Jürgen Konermann; Claas Lahmann; Thomas Loew; Karin Tritt Journal: Z Psychosom Med Psychother Date: 2009 Impact factor: 0.791
Authors: M Härter; P Sitta; F Keller; R Metzger; W Wiegand; G Schell; R-D Stieglitz; M Wolfersdorf; M Felsenstein; M Berger Journal: Nervenarzt Date: 2004-11 Impact factor: 1.214
Authors: Astrid Larisch; Gereon Heuft; Svenja Engbrink; Elmar Brähler; Wolfgang Herzog; Johannes Kruse Journal: Z Psychosom Med Psychother Date: 2013 Impact factor: 0.791
Authors: D Bichescu-Burian; C Cerisier; A Czekaj; J Grempler; S Hund; S Jaeger; P Schmid; G Weithmann; T Steinert Journal: Nervenarzt Date: 2017-01 Impact factor: 1.214